55095-17-5

Basic information

• Product Name: (4-bromophenyl)(phenyl)methylamine
• Synonyms: (4-bromophenyl)(phenyl)methylamine;OTAVA-BB 1179242;alpha-(4-BroMophenyl)benzylaMine;(4-broMophenyl)(phenyl)MethanaMine
• CAS NO: 55095-17-5
• Molecular Formula: C₁₃H₁₂BrN
• Molecular Weight: 262.149
• EINECS: 200-258-5
• Mol File: 55095-17-5.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 365.3°C at 760 mmHg
• Flash Point: 174.7°C
• Appearance: /
• Density: 1.383g/cm³
• Vapor Pressure: 1.58E-05mmHg at 25°C
• Refractive Index: 1.622
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (4-bromophenyl)(phenyl)methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: (4-bromophenyl)(phenyl)methylamine(55095-17-5)
• EPA Substance Registry System: (4-bromophenyl)(phenyl)methylamine(55095-17-5)

Safety Data

• Hazardous Substances Data: 55095-17-5(Hazardous Substances Data)

Usage

General Description

The chemical compound (4-bromophenyl)(phenyl)methylamine, also known as 4-bromodiphenylmethylamine, is an organic compound with the formula C13H12BrN. It is a aromatic amine derivative that consists of a brominated phenyl group and a phenylmethylamine group. (4-bromophenyl)(phenyl)methylamine is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. It is often used in the production of agrochemicals, pharmaceuticals, and organic materials. Its chemical structure and reactivity make it useful for various applications in the chemical and pharmaceutical industries.

InChI:InChI=1/C13H12BrN/c14-12-8-6-11(7-9-12)13(15)10-4-2-1-3-5-10/h1-9,13H,15H2

Upstream product

• 99763-24-3 (Z)-4-bromobenzophenone oxime 
• 118667-16-6 4-bromo-benzophenone-(E)-oxime 
• 55095-17-5 (4-bromophenyl)(phenyl)methanamine 
• 1445534-56-4 C₁₄H₁₀BrNO 
• 90-90-4 (4-bromophenyl)(phenyl)methanone 
• 127568-31-4 N-(4-bromo-benzhydryl)-formamide 
• 1122-91-4 4-bromo-benzaldehyde 
• 98-80-6 phenylboronic acid 
• 7440-44-0 pyrographite 
• 100-47-0 benzonitrile 
• 29097-44-7 (4-bromophenyl)(phenyl)methanimine 

Downstream Products

• 55095-17-5 (+)-4-bromo-benzhydrylamine 
• 55095-17-5 (-)-4-bromo-benzhydrylamine 
• 133175-56-1 (R)-N-[(R)-(4-Bromo-phenyl)-phenyl-methyl]-2-fluoro-2-phenyl-acetamide 
• 133175-65-2 (R)-N-[(S)-(4-Bromo-phenyl)-phenyl-methyl]-2-fluoro-2-phenyl-acetamide 
• 1428526-27-5 4-((4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(methyl)phosphonic acid 
• 1428526-84-4 4-((tert-butoxycarbonylamino)(phenyl)methyl)phenylphosphinic acid 
• 1428526-85-5 tert-butyl N-((4-(ethoxyhydrophosphoryl)phenyl)(phenyl)methyl)carbamate 
• 1428526-86-6 tert-butyl N-{[4-(ethoxy(propyl)phosphoryl)phenyl](phenyl)methyl}carbamate 
• 1428526-87-7 ethyl 4-(amino(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-88-8 ethyl 4-((4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-89-9 ethyl 4-((4-hydroxy-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenyl(propyl)phosphinate 
• 1428526-19-5 C₂₂H₃₀NO₅P 
• 1428526-21-9 diethyl 4-(amino(phenyl)methyl)phenylphosphonate 
• 1428526-23-1 diethyl 4-((4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)(phenyl)methyl)phenylphosphonate 

Relevant articles and documents

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.

SUBSTITUTED PYRIMIDINES

The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

METHODS OF PREPARING PRIMARY, SECONDARY AND TERTIARY CARBINAMINE COMPOUNDS IN THE PRESENCE OF AMMONIA

The present application relates to novel methods for the preparation of primary, secondary and tertiary carbinamine compounds, particularly the preparation of compounds of formulae I, IV and VI, from a carbonyl compound of formula II in the presence of ammonia or an ammonium equivalent of the formula NH4+X-, by way of allylation, crotylation, arylation, reductive amination and catalytic hydrogenation.